ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,047Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 517

$1.11M Total Retail Price of All Prescriptions

Rank: 17 out of 517

648 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 648 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,784 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 552 541 1 2
SIMVASTATIN 486 476 2 1
METFORMIN HCL 374 371 3 4
CELEBREX 352 352 4 40
NEXIUM 338 333 5 29
DIOVAN HCT 332 327 6 31
TAMSULOSIN HCL 306 294 7 22
OMEPRAZOLE 291 285 8 3
LIDODERM 258 254 9 49
CRESTOR 222 212 10 27
CREON 207 204 11 133
ATORVASTATIN CALCIUM 203 203 12 12
CLOPIDOGREL 200 200 13 47
ALENDRONATE SODIUM 195 193 14 11
AZITHROMYCIN 185 181 15 41
MELOXICAM 177 174 16 25
LOSARTAN-HYDROCHLOROTHIAZIDE 164 161 17 50
DONEPEZIL HCL 152 152 18 28
BENICAR HCT 144 133 19 166
METOPROLOL TARTRATE 143 138 20 18
ZOLPIDEM TARTRATE 141 141 21 14
EVISTA 140 138 22 102
DIOVAN 138 127 23 20
ATENOLOL 129 129 24 8
LISINOPRIL 127 126 25 7
FORTEO 115 115 26 253
LOSARTAN POTASSIUM 114 102 27 17
ALLOPURINOL 110 109 28 37
GLYBURIDE-METFORMIN HCL 110 105 R 28 57
PLAVIX 105 105 30 62
AVODART 104 104 31 99
BONIVA 102 101 32 165
JANUVIA 95 95 33 43
TRIAMCINOLONE ACETONIDE 92 91 34 32
METOPROLOL SUCCINATE 91 91 35 21
LEVOTHYROXINE SODIUM 89 89 36 6
NIASPAN 89 89 36 154
PREMPRO 89 86 R 36 331
DEXILANT 88 83 39 68
HYDROCODONE-ACETAMINOPHEN 83 82 S3 40 5
BENICAR 81 81 41 105
PEN NEEDLE 78 78 42 205
ISOSORBIDE MONONITRATE ER 76 76 43 70
ZENPEP 75 75 44 227
ACIPHEX 73 71 45 118
VOLTAREN 70 70 46 69
IBANDRONATE SODIUM 70 70 46 129
ALBUTEROL SULFATE 67 65 48 101
RANITIDINE HCL 67 66 48 54
FINASTERIDE 64 64 50 87
SINGULAIR 64 60 50 64
FENOFIBRATE 63 51 52 75
ACETAMINOPHEN-CODEINE 62 60 S3 53 48
GABAPENTIN 62 62 53 13
BENAZEPRIL-HYDROCHLOROTHIAZIDE 61 61 55 153
MICARDIS HCT 61 61 55 252
LYRICA 60 60 57 122
GEMFIBROZIL 58 57 58 80
DOXAZOSIN MESYLATE 57 57 59 104
PATADAY 56 56 60 138
ACTONEL 54 54 61 109
ECONAZOLE NITRATE 52 51 62 145
CILOSTAZOL 51 51 63 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.